Antibiotics and Bacterial Infections

Next Generation Approaches

The increasing fear of drug-resistant superbugs is leading to a growing push for the next generation of antibiotics. The development of new antibiotics is crucial to controlling current and future infectious diseases caused by antibiotic resistant bacteria. The discovery of a new antibiotic called teixobactin was announced by international team of researchers in 2017. The researchers now plan on studying the bacteria and decide what tools might be able to control its behavior to release its full antibiotic potential. An expected 5–10% of all hospitalizations are perplexed by a nosocomial disease with an expected cost of $4.5–5.7 billion every year in the USA alone. More varieties of biological solution are yet to be discovered in this field.